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Objective: Women with a longstanding history of recurrent urinary tract infections (RUTIs) represent a
challenging population because of gradual development of antibiotic resistance and frequent antibiotic
allergies. We report on the long-term results of womenwith RUTIs and trigonitis who were treated using
endoscopic fulguration and were prospectively followed.
Materials and methods: Following institutional review board approval, charts of non-neurogenic women
with RUTIs (deﬁned as 3 UTIs/y), no voiding dysfunction or incontinence, and normal upper tracts by
imaging, who underwent cystoscopy with fulguration of trigonitis (CFT) under anesthesia with 1 year
minimum follow up after CFT, were reviewed. Trigonitis was deﬁned as a condition of inﬂammation of
the trigone region of the bladder. The primary outcome was complete resolution of trigonitis based on
follow-up ofﬁce cystoscopy 6 months after CFT. The secondary outcome was the total number of anti-
biotic courses (AC) prescribed for UTI-related symptoms and/or positive urine cultures (PUC) following
CFT. We hypothesized that patients with complete trigonitis resolution after CFT fared best.
Results: From 2004 to 2008, 33 women met the inclusion criteria with a mean follow up of 48 ± 19
months (range, 14e82 months). Resolution of trigonitis at 6 months was noted in 25 (76%) patients. This
group averaged 0.51 ± 0.5 total AC and/or PUC/y compared with 2.03 ± 1.1 total AC and/or PUC/y for
women with persistent trigonitis following CFT (p ¼ 0.006).
Conclusion: Patients with resolved trigonitis at 6 months after CFT did best; however, both groups
beneﬁted from the procedure over time.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Women with recurrent urinary tract infections (RUTIs) are
increasingly frequent and difﬁcult to treat, in part because of drug
allergies, side effects, and resistant strains.1e3 There have been
advances in the understanding of the pathogenesis of UTIs in
recent years that may explain the difﬁculty in treating RUTIs. In
addition to retrograde ascent of bacteria up the urethra,4 studies
in animal models have indicated that other mechanismsmay be at
play, including formation of quiescent intracellular reservoirs.5
Trigonitis is a condition of inﬂammation of the trigone region of
the bladder diagnosed visually during cystoscopy. We hypothe-
sized that in women with RUTIs and trigonitis, the trigone may be
the reservoir site for UTI reinfection. Therefore, starting in 2004,l Center, 5323 Harry Hines
n.edu (P.E. Zimmern).
ociation. Published by Elsevier Tawe chose to eradicate these sites using a minimally invasive
outpatient technique consisting of cystoscopy with fulguration of
trigonitis (CFT). The feasibility of such an approach has already
been tested by Costantini et al6 using laser therapy, albeit in a very
different subset of women with irritative symptoms and negative
urine cultures. As time progressed, additional studies were per-
formed in association with our microbiology unit, including
trigonal biopsies to isolate bacterial species7 and test their ability
to form a bioﬁlm. This was made possible by the fact that CFT was
done under general anesthesia and the site of biopsy was treated
as part of the fulguration procedure. Furthermore, since 2007, CFT
has been performed with other procedures such as urethral
dilation, anterior compartment prolapse repair, or during bulking
agent injections, and those patients have been followed over time
in an institutional review board-approved long-term prospective
study.
In this report, we were interested to ﬁnd out if the initial group
of women with RUTIs treated with only CFT (and no additionaliwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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cation of these presumed chronic bacterial reservoir sites from the
trigone had a durable impact. Therefore, the aim of this study was
to review the long-term outcome of women with RUTIs treated
with CFT alone, including the rate of UTI recurrences following CFT.
2. Materials and methods
Medical charts of women who underwent CFT for RUTIs were
reviewed from a prospectively maintained, institutional review
board-approved, database. Included in the study were non-
neurogenic women with RUTIs who had failed multiple courses
of antibiotic therapy, had normal upper tract imaging studies, had
at least 1 year of follow up, and underwent an ofﬁce cystoscopy at 6
months after their CFT procedure. RUTI was deﬁned as three or
more UTIs/y. Exclusion criteria included neurogenic bladder, in-
continence or voiding dysfunction requiring additional procedures
at the time of CFT, and uncontrolled diabetes. Men were excluded
due to small sample size. Also, patients who did not undergo
follow-up ofﬁce cystoscopy at 6 months, or patients with compli-
cating urological factors that predisposed them to RUTIs such as
chronic intermittent catheterization or indwelling catheters, were
excluded. Demographic information, clinical examination, labora-
tory data including urinalysis and urine culture results, pre- and
postoperative cystoscopic ﬁndings, imaging studies, and subse-
quent treatment data were collected from an electronic medical
record (EPIC) and reviewed by a neutral investigator not involved
with patient care.
There is no single evidence-based, accepted deﬁnition of RUTI to
date; however, most literature deﬁnes RUTIs as three episodes of
UTIs in the past 12 months or two episodes in the past 6 months.1,8
For our study, RUTI was deﬁned as three or more episodes of un-
complicated (symptomatic) UTIs/y, with at least one documented
positive culture in the past year. Trigonitis was deﬁned as a chronic
mucosal inﬂammation of the trigone region (not pseudomem-
branous trigonitis) or squamous metaplasia of the trigone,9 and
was diagnosed during ﬂexible urethrocystoscopy. Urethrocysto-
scopy consisted of a methodical inspection of the urethra for areas
of urethritis and bladder neck polyps along with the trigone,
bladder, and bladder neck (including retroﬂexion). Fig. 1 provides a
typical example of trigonitis with pus pockets, bullous lesions, and
submucosal calciﬁcations. All endoscopic procedures were docu-
mented with pictures and performed by the same experienced
urologist and/or his trained physician assistants. Women withFig. 1. (A) Flexible cystoscopy performed before fulguration reveals characteristic trigoni
inﬂammation shows two large mucosal pus containing pockets.normal imaging of their upper urinary tracts, trigonitis ﬁndings,
and RUTIs refractory to multiple courses of antibiotic therapy un-
derwent a CFT procedure. However, women with incidental trig-
onitis ﬁndings on cystoscopy, but no history of RUTI were not
included in this study.
CFT was performed on an outpatient basis under anesthesia
using a 17.5-French female urethroscope and a ﬁne-tip Bugbee
electrode on a low setting of 20 to cauterize all inﬂammatory areas
involving the trigone, or any adjacent inﬂammatory lesions that
have spread beyond the margins of the trigone (Fig. 2). All pro-
cedures were performed by the same surgeon. Patients were dis-
charged home on the day of surgery without a urethral catheter.
At or near 6 months after CFT, patients routinely underwent
ofﬁce cystoscopy to assess trigonal healing. This procedure was
done after documentation of a negative urinalysis. Therefore, all
studied patients had no ongoing infection at the time of this follow-
up ofﬁce cystoscopy. A healed trigone has complete resolution of
trigonitis with no new lesions over the conﬁne of the trigone. This
follow-up ofﬁce procedure was performed by a variety of clinicians
(fellow trainees, physician assistants, or urologists). Pictures ob-
tained for documentation were reviewed and compared with pre-
operative and intraoperative CFT photographs to objectively
document persistence or resolution of trigonitis. Patients were
monitored long-term for repeat episodes of UTIs as documented by
positive urine cultures (PUC), and/or any antibiotic courses (AC)
prescribed for lower urinary tract symptoms suggestive of UTI,
whether accompanied by a urine culture or not. The independent
reviewer tallied these two outcome measures (PUC and AC) from
EPIC without the knowledge of the cystoscopic ﬁndings at 6
months after CFT to avoid interpretation bias.
The primary outcome measure was complete resolution of
trigonitis on follow-up ofﬁce cystoscopy (Fig. 2), with photographic
documentation preserved in EPIC. Secondary outcomes, deter-
mined through querying EPIC, were the total number of AC pre-
scribed for UTI-related symptoms and/or PUC in the years following
CFT. Not all women with PUC were treated and vice versa, not all
womenwho received AC obtained a urine culture before treatment.
Therefore, one or both of these events (AC and/or PUC) was chosen
to study the course of RUTIs after CFT. Because these patients
experienced 3 UTIs/y pre CFT, patients with zero total AC and/or
PUC over the follow-up period after CFT were deﬁned as “cured” of
RUTI. Thosewho averaged between 0 UTIs/y and 2 UTIs/y, andmore
than two AC and/or PUC per year were deﬁned as “improved” and
“no improvement”, respectively. Of note, in this study, it wastis with bullous edema and submucosal calciﬁcations. (B) A closer view of trigonal
Fig. 2. At 6 months following cystoscopy with fulguration of trigonitis (A), ofﬁce cystoscopy reveals a well healed trigone with no areas of residual trigonitis on retroﬂex view of the
trigone (B).
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these patients were neither maintained on long-term antibiotic
prophylaxis or coital prophylaxis, nor receiving cranberry
supplements.
Data were analyzed using standard statistical software, SAS
version 9.2 (SAS, Cary, North Carolina). The difference between the
total number of AC and PUC over the total follow-up period for the
two groups was compared using two-tailed paired t test for
continuous variables and categorical values were compared using
the Fisher's exact test. All results were evaluated at the p < 0.05
signiﬁcance level.
3. Results
From 2004 to 2008, 33/92 women met strict study criteria with
a mean follow up of 48 ± 19 months (range, 14e82 months).
Excluded women were: neurogenic (5), had urethral dilation pro-
cedure (47), concurrent injectable agents (6), and were lost to
follow up (1). Patient demographics are presented in Table 1. The
majority were Caucasian, with a mean age of 70 ± 13 years (range,
37e92 years), and mean body mass index (BMI) of 25 ± 5. Due to
their fear of having another UTI between their ofﬁce visit and the
CFT procedure that could lead to a cancellation of the CFT proce-
dure, 14/33 women (42%) elected to stay on a daily low dose anti-
biotic prophylaxis for a few days before their CFT procedure;Table 1
Baseline characteristics of women with successful and failed resolution of
trigonitis based on ofﬁce cystoscopy at 6 months after cystoscopy with
fulguration of trigonitis (CFT).
Successful CFT
(n ¼ 25)
Failed CFT
(n ¼ 8)
p
Follow up (mo) 50 ± 19 41 ± 19 0.19
Range: 21e82 mo Range:14e63 mo
Caucasian 96 100 > 0.99
Age (y) 68 ± 14 76 ± 11 0.13
BMI 25 ± 6 23 ± 3 0.37
Parity 2 ± 2 0.7 ± 1 0.09
Urinary 56 63 > 0.99
Hysterectomy 68 50 0.42
Menopause or
oophorectomy
65 50 0.68
Hormonotherapy 24 25 > 0.99
Sexually active 36 50 0.68
Diabetes 12 0 0.56
Data are presented as mean ± SD or %.
BMI ¼ body mass index; SD ¼ standard deviation.however, none stayed on long-term antibiotic prophylaxis after the
CFT procedure.
Twenty ﬁve (76%) patients had a successful resolution of trig-
onitis after the CFT procedure, with a mean duration of follow up of
50 ± 19months (range, 21e82months), a mean age of 68 ± 14 years
(range, 37e88 years), and mean BMI of 25 ± 6. Among the eight
patients with failed resolution of trigonitis based on ofﬁce cystos-
copy at 6 months, the mean duration of follow up was 41 ± 19
months (range, 14e63 months), with a mean age of 76 ± 11 years
(range, 59e92 years), and mean BMI of 23 ± 3. Baseline charac-
teristics of both groups of patients are given in Table 1, and include
the percentage of patients who were sexually active, had a hys-
terectomy, were incontinent, had diabetes, were on hormone
replacement therapy, or were postmenopausal or had a bilateral
oophorectomy. Overall, the baseline characteristics between both
groups were statistically similar. Upper tract imaging was normal in
all patients and no perioperative complications occurred. A com-
parison of preoperative versus postoperative urine cultures was of
limited value in the success group, but was of greater value in the
failure group, with six of eight women with similar bacterial
strains; Escherichia coli (4), Enterococcus (2). The cystoscopically
cured group averaged 0.51 ± 0.5 total AC and/or PUC/y compared
with 2.03 ± 1.1 total AC and/or PUC/y for patients with some degree
of persistent trigonitis by cystoscopy following CFT (p ¼ 0.006;
Table 2). Long-term outcomes, categorized as RUTI cure, improve-
ment, or no improvement, are presented in Table 3. Thirty-two
percent of the successful CFT group were completely cured. Over-
all, out of all patients treated with CFT, 30/33 (91%) patients were
cured or improved following CFT.
4. Discussion
In this study we found that womenwhowere cured of trigonitis
lesions through CFT fared signiﬁcantly better than those who hadTable 2
Mean number of antibiotic courses and/or positive urine cultures recorded for uri-
nary tract infection-related symptoms during the follow-up period in both groups of
patients.
Follow up (mo),
mean ± SD
Average AC and/or
PUC/y after CFT,
mean ± SD
Successful CFT (n ¼ 25) 50 ± 19 0.51 ± 0.5
Failed CFT (n ¼ 8) 41 ± 19 2.03 ± 1.1
p ¼ 0.006
AC ¼ antibiotic courses; CFT ¼ cystoscopy with fulguration of trigonitis;
PUC ¼ positive urine cultures; SD ¼ standard deviation.
Table 3
Long-term outcomes, categorized as RUTI cured, improved, or no improvement.a
Successful CFT (n ¼ 25) Failed CFT (n ¼ 8)
Cured 8 (32) 0 (0)
Improved 17 (68) 5 (63)
No improvement 0 (0) 3 (37)
Data are presented as n (%).
AC ¼ antibiotic courses; CFT ¼ cystoscopy with fulguration of trigonitis;
PUC ¼ positive urine cultures; RUTI ¼ recurrent urinary tract infection;
UTIs ¼ urinary tract infections.
a Patients who experienced 3 UTIs/y pre CFT, and patients with zero total AC
and/or PUC over the follow-up period after CFT were deﬁned as “cured” of RUTI.
Patients who averaged between 0 UTIs/y and 2 UTIs/y, and those with two or more
AC and/or PUC/y were deﬁned as “improved” and “no improvement”, respectively.
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months after CFT. This ﬁnding (in addition to subsequent work on
cultures of trigonal biopsies in these patients) supports the hy-
pothesis that an infected trigone can serve as a reservoir for RUTIs.
Moreover, both successful and failed groups showed improvement
in UTI recurrence compared with pre CFT status.
There have been advances in the understanding of the patho-
genesis of UTIs in recent years that may explain the link between
an animal model for acute UTI and the ﬁndings of this study. A UTI
is thought to begin with bacteria ascending into the bladder via
the urethra.4 However, recent studies in a mouse model suggest
that this is not always the case. Uropathogenic E. coli (UPEC) ex-
presses type 1 pili, an adhesion that allows for attachment of UPEC
to bladder epithelium.10 Once the UPEC have attached to the
urothelium, they are internalized by the cells and rapidly
multiply.11 Following surface exfoliation, bacteria can invade
deeper layers, resulting in quiescent intracellular reservoirs.5,12
Importantly, intracellular UPEC appears to be protected from a
number of antibiotics, including mecillinam, cefuroxime, genta-
micin, and trimethoprim-sulfamethoxazole.13e15 In fact, in one
mouse model of UTI, a signiﬁcant amount of UPEC could be found
months after antibiotic treatment.16 Although not clearly estab-
lished in humans, a similar cascade of events may result in RUTI,
and could explain why these patients suffer from several bouts of
infection despite multiple AC. Therefore, as supported by our re-
sults and signiﬁcant long-term improvement in >90% of our pa-
tients treated with CFT, removal of these reservoirs in the trigone
may have a superior beneﬁt over prolonged and repeated antibi-
otic treatment courses.
Our results compare favorably with those of Costantini et al6
who prospectively analyzed 62 consecutive women who under-
went laser diathermy of the trigonewith either a side- or end-ﬁring
laser for refractory urethral syndrome consisting of urgency, fre-
quency, and/or pain associated with negative urine cultures. At a
mean follow up of 49 months, 68% of the patients who underwent
side-ﬁring laser had at least a 75% improvement in urinary symp-
toms. Although no patient had an active UTI, 61% had a history of
UTIs, and the authors noted that these patients tended to improve
more. They concluded that side-ﬁring laser, which produced
necrotic coagulation followed by reconstitution of normal func-
tional epithelium, was signiﬁcantly more successful and may
destroy ‘bacterial factories’ in the bladder epithelium.6 Therefore, in
their study, as in ours, removal of bacterial reservoirs in the trigone
provided satisfactory results in the long run.
The clinical management of RUTIs includes, among others,
vaginal estrogen therapy alone or in association with long-term
prophylactic antibiotics.12 In this contemporary series, the use of
vaginal estrogen was relatively low, a ﬁnding tempered by a high
rate of postmenopausal status in this cohort, the cost of oestrogen
supplementation (which can be a deterrent), and the lack of sexualactivity in >50% of the participants. With regard to women with
frequent UTIs who take prophylactic antimicrobial agents for
extended periods, their rate of UTI will decrease while on pro-
phylaxis, but will return to pretreatment rates once their prophy-
laxis is stopped.13,14 A Cochrane review of the literature indicated
that such a prophylactic regimen can decrease the incidence of
RUTIs in women.1 However, that Cochrane meta-analysis deter-
mined that side effects are frequently seen in >20% of patients on
antibiotic prophylaxis, and most commonly involve vaginal or oral
candidiasis and digestive problems.1 Therefore, enthusiasm for this
prophylactic antibiotic-based approach can wane after patients
experience adverse effects or when resistant bacteria arise. Lack of
patient compliance and cost of medication are additional issues
confronting patients on long-term prophylactic antibiotic treat-
ment. Taken together, these multiple challenges related to vaginal
estrogen supplementation and/or long-term antibiotic usage make
CFT an appealing option, because it is a brief outpatient procedure
with minimal side effects and clinical beneﬁt as supported by our
long-term results.
CFT as an alternative to long-term prophylactic antibiotic usage
might also be viewed favorably as it could contribute to reducing
the progression of antibiotic resistance. In the Antimicrobial
Resistance Epidemiology in Females with Cystitis (ARESC) study,
which consisted of nine European countries and Brazil, fosfomycin,
mecillinam, and ciproﬂoxacin were found to have susceptibility
rates of >90% for all countries, whereas antibiotics like ampicillin
had a susceptibility rate of only 45%, cotrimoxazole of 70.5%, and
amoxi-calvulanate of 82%.17 Therefore, lower susceptibility rates in
conjunction with the frequent development of side effects in pa-
tients with a longstanding history of RUTIs increase treatment
complexity and encourage the development of alternative
therapies.
There are several strengths of this study: a single surgeon per-
formed all CFT procedures; strict exclusion criteria were used so
that women with additional voiding dysfunction requiring addi-
tional interventions (neurogenic bladder, urethral dilation, cys-
tocele repair, etc.) were not studied as the pure beneﬁt of the CFT
procedure would have been harder to decipher; the primary
outcome was based on cystoscopy at 6 months following CFT per-
formed by various investigators and using photographic docu-
mentation pre- and postoperatively to allow neutral review of the
CFT results; and long-term (mean 48 months) follow up was
longitudinally collected. Therefore, the indication to proceed with
CFT was very focused on women with RUTIs and extensive trig-
onitis with no additional procedure performed at the same setting.
Additionally, the use of an electronic medical record facilitated the
retrieval of UTI episodes by documenting the number of antibiotics
prescribed for UTI-related symptoms and/or PUC results. Limita-
tions included the limited cohort, the deﬁnition of trigonitis which
is based on visual recognition (Fig. 1), and the possibility of patients
receiving antibiotic therapy outside of our clinical setting or for a
different condition. In addition, the numbers were too small to
determine if sexual activity might have served as a contributory
factor in the failure group. Other explanations for the failure group
could be technical, suggesting the presence of bacteria already
anchored to the bladder lining beyond the conﬁnes of the trigone
and not visibly detectable or possibly liberated during the fulgu-
ration procedure itself. We have used gentamicin irrigation at the
end of the procedure in some patients (since then and not in this
series) but have not observed an additional beneﬁt. Likewise,
although the current trend favors a decrease in use of hormonal
supplementation, the form of hormonal therapy (systemic or
vaginal estrogen or both)might have ﬂuctuated among participants
over the course of the study follow up. Future studies with a larger
patient population and the inclusion of subgroups that were
S.A. Hussain et al. / Urological Science 26 (2015) 197e201 201excluded in this study will be needed to corroborate this initial
series.
5. Conclusion
In this retrospective study of a prospectively maintained data-
base on non-neurogenic women with longstanding RUTIs re-
fractory to multiple prior AC, fulguration of trigonitis resulted in a
complete cystoscopic resolution of the trigonal lesions at 6 months
postoperatively in 76% of the cohort. In this successful group, there
was a signiﬁcantly decreased need for antibiotic treatments for UTI-
related symptoms and/or PUC results compared with the failure
group with residual trigonitis. Therefore, CFT should be considered
in the armamentarium of women with RUTI as growing antibiotic
resistance, side effects, and cost, frequently complicate the care of
these challenging patients.
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